Novel oral vasodilator approved to treat pulmonary hypertension
Pediatric News ,
Riociguat, a potent vasodilator that is the first in a new class of drugs, has been approved by the Food and Drug…
Adempas PAH Benefits Extend to SSc
MedPage Today,
Action Points Treatment with riociguat (Adempas) increased exercise capacity among patients whose pulmonary arterial…
FDA Panel Recommends Approval For Pulmonary Hypertension Drug From Bayer
Forbes,
The FDA's Cardiovascular and Renal Drugs Advisory Committee recommended approval for Bayer's new pulmonary hypertension drug…
Novel Agent Eases PAH Disability (CME/CE)
MedPage Today,
(MedPage Today) -- The investigational agent riociguat (proposed trade name Adempas) improved exercise capacity and other…